Pensionfund Sabic Sells 1,500 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Pensionfund Sabic lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 19.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,300 shares of the healthcare conglomerate’s stock after selling 1,500 shares during the period. UnitedHealth Group makes up about 1.1% of Pensionfund Sabic’s holdings, making the stock its 15th biggest position. Pensionfund Sabic’s holdings in UnitedHealth Group were worth $3,683,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of the company. BSN CAPITAL PARTNERS Ltd purchased a new position in UnitedHealth Group in the 3rd quarter worth approximately $28,369,000. Wealth Group Ltd boosted its position in UnitedHealth Group by 4.0% during the 3rd quarter. Wealth Group Ltd now owns 1,777 shares of the healthcare conglomerate’s stock valued at $1,039,000 after buying an additional 68 shares during the period. High Note Wealth LLC grew its position in shares of UnitedHealth Group by 0.4% in the 3rd quarter. High Note Wealth LLC now owns 23,173 shares of the healthcare conglomerate’s stock worth $13,549,000 after buying an additional 89 shares during the last quarter. Patten Group Inc. boosted its holdings in UnitedHealth Group by 2.5% in the third quarter. Patten Group Inc. now owns 5,679 shares of the healthcare conglomerate’s stock valued at $3,320,000 after acquiring an additional 139 shares in the last quarter. Finally, Wedmont Private Capital boosted its holdings in UnitedHealth Group by 12.2% in the third quarter. Wedmont Private Capital now owns 12,280 shares of the healthcare conglomerate’s stock valued at $7,166,000 after acquiring an additional 1,339 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 1.7 %

NYSE:UNH opened at $591.22 on Thursday. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $607.94. The company has a market cap of $545.94 billion, a price-to-earnings ratio of 36.14, a price-to-earnings-growth ratio of 1.65 and a beta of 0.58. The stock has a fifty day simple moving average of $582.98 and a 200-day simple moving average of $529.56. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating the consensus estimate of $6.66 by $0.14. The firm had revenue of $98.86 billion during the quarter, compared to the consensus estimate of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm’s quarterly revenue was up 6.4% on a year-over-year basis. During the same period in the previous year, the company posted $6.14 earnings per share. Analysts anticipate that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.42%. UnitedHealth Group’s payout ratio is 51.34%.

Analysts Set New Price Targets

A number of brokerages have recently commented on UNH. UBS Group boosted their target price on shares of UnitedHealth Group from $640.00 to $680.00 and gave the company a “buy” rating in a report on Thursday, July 18th. Wells Fargo & Company boosted their target price on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Royal Bank of Canada upped their price target on shares of UnitedHealth Group from $555.00 to $615.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. Morgan Stanley boosted their price objective on UnitedHealth Group from $595.00 to $615.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a research note on Tuesday, October 1st. Two research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus target price of $614.17.

Insider Transactions at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares in the company, valued at $4,507,748.55. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.